Medical Device Regulatory Services in Canada and the U.S.
Helping Medical Device brands successfully enter and grow in the Canadian/U.S. market since 2004.
Medical devices are regulated products used for diagnosis, treatment, monitoring, and prevention. In Canada, they fall under the Medical Device Regulations, and in the United States they are governed by the Code of Federal Regulations (CFR) and overseen by the FDA. Both countries use a risk-based classification system, with four classes in Canada and three in the United States, each requiring specific licensing pathways, evidence standards, and compliance obligations before a device can be marketed.
Navigating these requirements can be complex. SNI’s Regulatory Affairs team provides end-to-end medical device consulting to help manufacturers, importers, private label distributors, and innovators meet Health Canada and FDA expectations.
Medical Device Regulatory Experts You Can Rely On
SNI combines regulatory consulting experience with deep industry insight to translate Health Canada and FDA requirements into practical, market-ready strategies. With more than 20 years of industry legacy and over 100 years of combined regulatory, clinical, quality, and subject-matter expertise, our team helps medical device developers balance safety, performance, and innovation while preparing for market entry.
As global demand for advanced medical technologies continues to grow, regulatory expectations in both Canada and the U.S. remain increasingly rigorous. Our specialists support you in interpreting these requirements, assessing risk classification, and preparing the documentation needed for compliant market access.
We offer support a broad range of medical devices, including products containing:
- Pacemakers
- Artificial heart valves
- Hip implants
- Syringes
- Diagnostic laboratory instruments
- Digital health and software-based devices
- Wearable medical technologies
- Microcurrent devices
- Combination-products
- Contraceptive devices
- Red-light therapy devices
- Contact lenses
- Insulin pumps
Our team ensures accurate classification and confirms the appropriate licensing requirements for both the Canadian and U.S. markets.
Our Medical Device Regulatory Services
We provide comprehensive support across the full medical device lifecycle.
Regulatory Strategy and Product Classification
- Device classification assessments for Canada and the U.S.
- Regulatory feasibility reviews
- Strategic planning for device licensing and market entry
Submission Preparation and Regulatory Applications
- Canadian Medical Device Licence preparation (Class II, III, IV)
- Medical Device Establishment Licence (MDEL) support for manufacturers, importers, and distributors
- U.S. Establishment Registration and Medical Device Listing
- Premarket Notification 510(k) submissions
- Premarket Approval (PMA) submissions
- Investigational Device Exemption (IDE) submissions
Labelling Packaging and Design Compliance
- Medical device manual and label review in accordance with Health Canada and FDA requirements
- Assessment of required elements, including indications, contraindications, warnings, manufacturer identification, and traceability information
- Packaging compliance reviews for device class, sterilization status, and storage requirements
- Branding and claims positioning that aligns with regulatory guidance
- Translation services for on and off label marketing
Clinical Evidence and Claim Substantiation
- Study feasibility support that assesses recruitment potential, operational readiness, timelines, and regulatory expectations
- Development of scientifically sound and regulatorily aligned clinical study designs and protocols tailored to device use and risk level
- Participant recruitment planning and coordinated study execution that ensures consistent, high-quality data collection
- Data analysis using validated methodologies, followed by interpretation that translates findings into clear safety and performance narratives
- Preparation of clinical evidence packages and summaries that substantiate device safety and efficacy
Quality and Post-Market Support
- Quality assurance support that aligns with Health Canada and FDA quality system expectations
- Documentation review and readiness assessments for MDEL, licensing, and inspections
- Guidance for complaint handling, product recalls, and mandatory reporting obligations
- Support for ongoing post-market compliance, including label updates and lifecycle documentation
- Assistance with standard operating procedure (SOP) development, document control, and quality record maintenance
- Translation services for required documents and labelling
How Our Medical Device Consulting Process Works
Step 1: Discovery and Feasibility:
We assess your device’s classification, intended use, risk profile, evidence, and regulatory pathway.
Step 2: Regulatory Strategy and Documentation Planning:
We outline the optimal approach for regulatory submissions, including evidence requirements, quality documentation, and licensing timelines.
Step 3: Submission and Regulatory Liaison:
We prepare and submit your application and manage all communication with Health Canada or the FDA throughout the review process.
Step 4: Post-Licence and Lifecycle Support:
We ensure your device remains compliant as your product evolves. This includes labelling changes, post-market obligations, and quality updates.
A Trusted Regulatory Partner for Market Entry
Bringing a medical device to market requires technical accuracy, strong evidence, and clear understanding of regulatory pathways. SNI supports your development and commercial objectives by aligning regulatory expectations with your business goals.
Our integrated model connects Regulatory Affairs, Clinical Research, Quality Assurance, and Creative Services to ensure your device launches successfully and maintains compliance throughout its lifecycle.
